Up 09.8%. 2012 Portfolio gain to date Up 01.9%. 2012 Pfizer stock price gain to date including one 22-cent dividend
Note: This portfolio had a steady cost basis of $100,000 from 11/17/04 inception through 6/2/08. From that date through mid-March of 2009, additional funds were invested until the cost basis reached $296,110. The basis has remained steady again since that time.
Note: This portfolio was up by as much as 96K pre-crash on 6/1/07 with the stock closing at $27.68 that day. It was also down as much as 333K on 3/2/09 when the stock closed at $11.66. Gains of $234,485 from inception were seen on 3/16/12 with the stock at $21.94.
Note: Over time, the leverage factor at these portfolio levels is about 1.9, the lowest since inception. Note: Average annualized gains from inception stands at 7.9% and considers all additional funds needed to margin the naked puts.
An extended period where the stock does little is like manna from heaven as the very deep-in-the-money long calls hold their value while value continually ebbs away from the covered calls and naked puts.